FDAnews
www.fdanews.com/articles/96474-ranbaxy-forays-into-authorised-generics-in-u-s

Ranbaxy Forays Into Authorised Generics in U.S.

July 30, 2007

Pharmaceutical major Ranbaxy Laboratories on Monday said it has commercialised its first authorised generic product, Isoptin SR — an antihypertensive agent — in the U.S. market.
The Economic Times